A retrospective study of Botox and Dysport, in patients with hemifacial spasm, facial synkinesis and benign essential blepharospasm
Latest Information Update: 21 Jul 2021
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Botulinum-Toxin-A (Primary)
- Indications Blepharospasm; Hemifacial spasm; Muscle spasticity
- Focus Adverse reactions; Therapeutic Use
- 21 Jul 2021 New trial record
- 25 Jun 2021 Results published in the Medicine